Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06487039Phase 2Unknown
Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration
Neovascular Age-related Macular Degeneration (nAMD)
PrincipalinvestigatorStart date: 2024-08-01

Research Network

Collaboration Network

5 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Inje University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sotaro Takigawa

Kyowa Kirin Co., Ltd.

Moderately Similar
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration (nAMD)
Similarity Score30%

Amir Shojaei, PhD

Asclepix Therapeutics

Moderately Similar
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration (nAMD)
Similarity Score30%

Dilsher Dhoot, MD

California Retina Consultants (CRC)-Bakersfield

Moderately Similar
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration (nAMD)
Similarity Score30%

Miklos Schneider, MD, PhD

Glostrup University Hospital, Copenhagen

Moderately Similar
3 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration (nAMD)
Similarity Score30%

Jakkrit Juhong, MD

Walailak University

Moderately Similar
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration (nAMD)
Similarity Score30%

Director the Eye Clinic

LMU Klinikum Eye Clinic

Moderately Similar
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration (nAMD)
Similarity Score30%

Julie Tsai, MD

4D Molecular Therapeutics

Moderately Similar
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration (nAMD)
Similarity Score30%

Roger Goldberg, MD

Lexitas Pharma

Moderately Similar
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration (nAMD)
Similarity Score30%

Adam Turpcu, PhD

Adverum Biotechnologies, Inc.

Moderately Similar
4 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration (nAMD)
Similarity Score30%

Iksoo Byon

Pusan National University Hospital

Related
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration (nAMD)

Worked with same sponsors:

EyebioKorea, Inc.
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06487039Phase 2PrincipalInvestigator

Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration (nAMD)
Unknown

All 1 trials loaded